TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
84.87
-3.56 (-4.03%)
At close: Aug 31, 2026, 4:00 PM EDT
84.50
-0.37 (-0.44%)
After-hours: Aug 31, 2026, 7:57 PM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.94 billion as of August 31, 2026. Its market cap has decreased by -24.91% in one year.
Market Cap
2.94B
Enterprise Value
3.34B
1-Year Change
-24.91%
Ranking
Category
Stock Price
$84.87
ChartMarket Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.94B, an increase of 550.39%. That is a compound annual growth rate of 29.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 2.94B | -29.21% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 4.69B |
| LivaNova | 4.40B |
| Integer Holdings | 4.26B |
| iRhythm Holdings | 3.92B |
| Axogen | 2.73B |
| Neogen | 2.52B |
| UFP Technologies | 2.31B |
| Alamar Biosciences | 2.12B |